712748004: Vortioxetine hydrobromide (substance)

SNOMED CT Concept\Substance\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Piperazine and/or piperazine derivative (substance)\Piperazine derivative\Vortioxetine hydrobromide

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3285338019 Vortioxetine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3285374011 Vortioxetine hydrobromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

32251000188114 vortioxétine bromhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

849801000172116 hydrobromure de vortioxétine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vortioxetine hydrobromide	Is a	Vortioxetine (substance)	false	Inferred relationship	Some
Vortioxetine hydrobromide	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Vortioxetine (substance)	true	Inferred relationship	Some
Vortioxetine hydrobromide	Is a	Piperazine derivative	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Vortioxetine (as vortioxetine hydrobromide) 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vortioxetine hydrobromide	Inferred relationship	Some	1
Product containing precisely vortioxetine (as vortioxetine hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vortioxetine hydrobromide	Inferred relationship	Some	1
Product containing precisely vortioxetine (as vortioxetine hydrobromide) 15 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vortioxetine hydrobromide	Inferred relationship	Some	1
Vortioxetine (as vortioxetine hydrobromide) 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vortioxetine hydrobromide	Inferred relationship	Some	1

This concept is not in any reference sets